Stay updated on Pembrolizumab and TKI in CML MRD Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and TKI in CML MRD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and TKI in CML MRD Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, replacing Revision: v3.5.3. This indicates a small update to the page's version label rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-05-15T04:14:44.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.5.3, replacing v3.5.2. This represents an internal metadata update with no changes to the study details or visible content.
    Difference
    0.0%
    Check dated 2026-04-30T18:25:17.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision: v3.5.2 has been added, replacing the previous Revision: v3.5.0 on the page.
    Difference
    0.0%
    Check dated 2026-04-16T10:31:02.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    New update dates (e.g., 2026-04-03, 2026-03-31) were added and older dates (e.g., 2026-03-02, 2026-02-27, 2026-02) were removed from the study record.
    Difference
    0.1%
    Check dated 2026-04-09T08:12:55.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    No additions or deletions are visible in the provided data; the page appears unchanged.
    Difference
    0.0%
    Check dated 2026-04-02T00:28:12.000Z thumbnail image
  8. Check
    52 days ago
    Change Detected
    Summary
    Screenshot comparison shows no content additions or deletions to core study information. The visible sections appear unchanged, including the brief summary, objectives, and eligibility criteria.
    Difference
    0.0%
    Check dated 2026-03-25T21:00:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and TKI in CML MRD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and TKI in CML MRD Clinical Trial page.